ResearcherUniversity of California, San FranciscoNo recent work listed

Angelina S. Bortoletto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7033-4274; OpenAlex author ID A5005461708. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced granules (KGs) Co-author DOI 10.21203/rs.3.rs-3064215/v1 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ronald J. Parchem · 1 shared paper, 2023 · strength 0.22
- Paper Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced g… DOI 10.21203/rs.3.rs-3064215/v1 ↗
Frank Patrick Mccormick · 1 shared paper, 2023 · strength 0.22
- Paper Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced g… DOI 10.21203/rs.3.rs-3064215/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.